期刊文献+

抗人IL-2Rα基因工程抗体Fab的构建和表达

Study on the construction and expression of anti-IL2Rα genetically engineering an-tibody Fab
暂未订购
导出
摘要 目的:构建和表达抗人IL-2Rα基因工程抗体Fab片段,并测定该抗体片段的生物学活性。方法:采用连续PCR方法构建抗人 IL-2Rα抗体 Fab克隆载体5G1-pA22,并通过限制性酶切反应将抗人 IL-2Rα抗体 Fab基因从克隆载体 5G1-pA22重组人表达载体pET-28b,并在大肠杆菌BL21(DE3)中用IPTG诱导以包含体形式高效表达,该表达产物约占菌体蛋白20%以上。经超声破碎、洗涤、变性和复性后,采用双抗体夹心ELISA法及体外抗体竞争抑制试验鉴定表达产物的生物学活性。结果:抗人IL-2Rα基因工程抗体Fab成功构建,并以包含体形式表达,表达产物的产量达1mg/ml。双抗体夹心ELISA法试验表明抗体 Fab段与 IL-2Rα有特异的结合能力,体外抗体竞争抑制实验表明 Fab段可桔抗 IL-2与活化T细胞表面 IL-2Rα有特异的结合,抑制T细胞活化,增殖,抑制率达90%以上。结论:成功地构建了抗人IL-2Rα抗体Fh段,并获得高效表达,其具有较好的生物学活性。 Abstract Objective: To construct and express anti-IL-2Rα genetically engineering antibody Fab and identify its biological activity.Methods: PCR were used to construct cloning vector 5G1-pA22 of anti-IL-2Rα antibody Fab,by digestion of vector 5G1-pA22, anti-IL-2Rα an-tibody Fab gene fragment was obtained and then this fragment was coupled with digesting product of pET28b plasmid by EcoRI and HindIII toget a recombinant expression vector 5G1-pET28b, it was highly expressed in the E. coli BL21(DE3) in the form of inclusion bodies, compoing20% of the total protein. After the renaturation of antibody Fab, its binding activity was identified by ELISA and antibody competitive inhibitionassay in vitro. Results: Anti-IL-2Rα antibody Fab was successfully constructed and highly expressed in the form of inclusion bodies, its yield wasup to 1 mg/ml.When applied to ELISA, antibody Fab exhibited good spectfic reactivity with rIL-2R, antibody competitive inhibition assay invitro indicated that antibody Fab can compete with IL-2 for binding IL-2R in activated T cell surface.As a result,the activation and proliferationof T cells were inhibited and inhibition percentage exceeded 90%. Conclusion: Had successfully constructed and expressed anti-IL-2Rα geneti-cally engineering antibody. Fab,it had good biological ativity.
作者 李佳莉 朱迅
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2002年第5期305-308,共4页 Chinese Journal of Immunology
基金 吉林省计委攻关课题资助项目
关键词 IL-2RΑ 基因工程抗体 FAB 基因表达 Keywords:IL-2Rα Recombinant antibody Fab
  • 相关文献

参考文献7

  • 1Cosimi A B. Future cfmonoclonal antibodies in solid organ transplantation [J]. Digestive Diseases and Sciences, 1995 ;40:65
  • 2Long D L. Monoclonal antibodies[J] .Ann Intem Med,1987;106:427
  • 3Horst H I, Flad H D. Corticosteroid IL-2 interaction: inhibition of binding of IL-2 receptor[ J]. Clin Exp Immnunol, 1987;68:156
  • 4Martin J G,Peter W M J. Clinical trials ofantibody therapy[J]. Immunol ogy Today,2000;21 (8) :403
  • 5Berard J L. A review of interleukin-2 receptor antagonist in solid organ transplantation[J]. Pharmacotherapy, 1999; 19:1127
  • 6Wiseman L R, Faulds D. Daclizumab: a review of its use in the preventiention of acute rejection in renal transplant recipients[J]. Drug, 1999;58(6): 1029
  • 7Sergey M K, Melvyn L. Generation of recombinant antibodies[J]. Molecu lar Biochem, 1999; 12:173

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部